CERC-611 (LY3130481)

PRECLINICAL
PHASE 1
PHASE 2
PHASE 3
PRE
P1
P2
P3
Edit

Updated: 05/17/2019

Pipeline Type

New Drugs in Development

Phase Of Development

Preclinical

Sponsors and Collaborators

Cerecor

Mechanism of Action

Glutamate

Mechanism Description

Modulate AMPA Receptors (AMPA antagonist)

Populations Tested In

Focal Seizures

Other Resources

Special FDA Designation

Nonprofit or Government Support

N/A

Nonprofit or Government Support Description

N/A

Previous Presentations

Presented at meetings (latest date) (Pipeline, AEDD; AES, Eilat, etc)
N/A

Location of Clinical Trials

N/A

Clinical Trial link

Sign Up for Emails

Stay up to date with the latest epilepsy news, stories from the community, and more.